ACET Insider Trading Activity and SEC Form 4 Filings
ACET insider trading summary
Over the past 12 months, insiders at Adicet Bio, Inc. (ACET) reported 32 sales worth $5.4M by 8 insiders and 12 open-market purchases worth $6.4M by 4 insiders on SEC Form 4. Net insider buying was $1.0M.
Latest ACET insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 8, 2026 | OrbiMed Israel GP Ltd. | 10% Owner | Sell | $205K (32,523 @ $6.29) |
| Apr 8, 2026 | OrbiMed Capital GP V LLC | 10% Owner | Sell | $205K (32,523 @ $6.29) |
| Apr 8, 2026 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell | $205K (32,523 @ $6.29) |
| Apr 8, 2026 | OrbiMed Israel GP II, L.P. | 10% Owner | Sell | $205K (32,523 @ $6.29) |
| Apr 8, 2026 | Orbimed Advisors LLC | 10% Owner | Sell | $264K (40,416 @ $6.52) |
| Apr 8, 2026 | OrbiMed Capital GP V LLC | 10% Owner | Sell | $264K (40,416 @ $6.52) |
| Apr 8, 2026 | Orbimed Advisors LLC | 10% Owner | Sell | $205K (32,523 @ $6.29) |
| Apr 8, 2026 | OrbiMed Genesis GP LLC | 10% Owner | Sell | $205K (32,523 @ $6.29) |
| Apr 8, 2026 | OrbiMed Capital GP VI LLC | 10% Owner | Sell | $205K (32,523 @ $6.29) |
| Apr 8, 2026 | OrbiMed Advisors Israel II Ltd | 10% Owner | Sell | $205K (32,523 @ $6.29) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.